Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches

被引：0
|
作者：
Nicole R. Grieselhuber
Alice S. Mims
机构：
[1] The Ohio State University Comprehensive Cancer Center,Division of Hematology, Department of Internal Medicine
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Acute myeloid leukemia; Targeted therapy; DOT1L; MDM2 inhibitors; Bromodomain inhibitors; Polo-like kinase inhibitors; Menin inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：192 / 206
页数：14
相关论文
共 50 条
  • [31] Choosing and sequencing novel drugs in CLL: dealing with an embarrassment of riches?
    Tam, C. S.
    Seymour, J. F.
    ANNALS OF ONCOLOGY, 2017, 28 (05) : 920 - 921
  • [32] Tumor protein 53 mutations in acute myeloid leukemia: conventional induction chemotherapy or novel therapeutics
    Asghari, Hannah
    Talati, Chetasi
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 66 - 75
  • [33] Acute myeloid leukemia therapeutics CARs in the driver's seat
    Mardiros, Armen
    Brown, Christine E.
    Budde, L. Elizabeth
    Wang, Xiuli
    Forman, Stephen J.
    ONCOIMMUNOLOGY, 2013, 2 (12)
  • [34] Multildrug resistance in acute myeloid leukemia: Potential new therapeutics
    Weisburg, Jeffrey H.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) : 1405 - 1407
  • [35] Pharmacologic Targeting of Chromatin Modulators As Therapeutics of Acute Myeloid Leukemia
    Lu, Rui
    Wang, Gang Greg
    FRONTIERS IN ONCOLOGY, 2017, 7
  • [36] Engineered biocompatible nanoparticles as potential therapeutics for acute myeloid leukemia
    Syrovets, T.
    Gaiser, A. -K.
    Hafner, S.
    Simmet, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 7 - 7
  • [37] Acute myeloid leukemia: advancing clinical trials and promising therapeutics
    Daver, Naval
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (05) : 433 - 445
  • [38] The changing face of acute myeloid leukemia therapeutics in the elderly population
    Daver, Naval
    Cortes, Jorge
    SOUTH ASIAN JOURNAL OF CANCER, 2015, 4 (01) : 1 - 2
  • [39] Development of Novel Model Systems for the Study of Resistance to Targeted Therapies in Acute Myeloid Leukemia
    Staudt, Dilana
    Duchatel, Ryan
    Kahl, Richard
    Murray, Heather
    Scott, Rodney
    Verrills, Nikki
    Dun, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 20 - 21
  • [40] Inhibitor of apoptosis protein antagonists as novel targeted chemotherapeutic agents for acute myeloid leukemia
    Finlay, Darren
    Bata, Nicole
    Limpert, Allison
    Heimann, Dominik
    Teriete, Peter
    Burian, Carol
    Mason, James
    Cosford, Nicholas D.
    Vuori, Kristiina
    CANCER RESEARCH, 2020, 80 (16)
12345